Antigen-specific immunity does not mediate acute regression of UVB-induced p53-mutant clones

Oncogene

Volumn 22, Issue 41, 2003, Pages 6369-6376

  Remenyik, Éva ^a,b,c   Wikonkál, Norbert M ^a,b,c,d   Zhang, Wengeng ^a,b   Paliwal, Vipin ^a,b   Brash, Douglas E ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Apoptosis; Epidermal thickness; Immune surveillance; Knockout; Rag1; Sunburn cells

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; RAG1 PROTEIN; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL MUTANT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; EPIDERMIS HYPERPLASIA; FEMALE; GENE MUTATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HOMEOSTASIS; IMMUNITY; KERATINOCYTE; KNOCKOUT MOUSE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION CARCINOGENESIS; SKIN CARCINOGENESIS; SKIN CARCINOMA; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; SUNBURN; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; WILD TYPE; ANIMAL; GENETICS; HUMAN; IMMUNE SYSTEM; METABOLISM; MOUSE MUTANT; MUTATION; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ANIMALIA; MURINAE;

ANIMALS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNE SYSTEM; MICE; MICE, KNOCKOUT; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0142103813     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206657     Document Type: Article

References (36)

1. Andrews EJ. (1971). J. Natl. Cancer. Inst., 47, 653-665.
2. Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF, van der Leun JC and de Gruijl FR. (1996). Proc Natl. Acad. Sci. USA, 93, 274-278.
3. Berton TR, Mitchell DL, Fischer SM and Locniskar MF. (1997). J. Invest. Dermatol., 109, 340-347.
4. Brash DE and Pontén J. (1998). Precancer: Biology, Importance, and Possible Prevention, Vol. 32: Cancer Surveys Pontén J (ed.). Cold Spring Harbor Press: Cold Spring Harbor, pp 69-113.
5. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ and Pontén J. (1991). Proc Natl. Acad. Sci. USA, 88, 10124-10128.
6. Burns FJ, Vanderlaan M, Sivak A and Albert RE. (1976). Cancer Res, 36, 1422-1427.
7. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y and Bendelac A. (1999). J. Immunol., 163, 4647-4650.
8. Daugelat S, Ladel CH, Flesch IE and Kaufmann SH. (1996). Immunol. Lett., 50, 81-85.
9. Daynes RA, Bernhard EJ, Gurish MF and Lynch DH. (1981). J. Invest. Dermatol, 77, 77-85.
10. DeFabo EC and Kripke ML. (1979). Photchem Photobiol., 30, 385-390.
11. de Gruijl FR, Sterenborg HJ, Forbes PD, Davies RE, Cole C, Kelfkens G, van Weelden H, Slaper H and van der Leun JC. (1993). Cancer Res, 53, 53-60.
12. Fisher MS and Kripke ML. (1977). Proc Natl Acad. Sci. USA, 74, 1688-1692.
13. Fisher MS and Kripke ML. (1982). Science, 21, 1133-1134.
14. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE and Hayday AC. (2001). Science, 294, 605-609.
15. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE and Brash DE. (1996). Proc. Natl. Acad. Sci. USA, 93, 14025-14029.
16. Kemp CJ, Vo K and Gurley KE. (1999). Carcinogenesis, 20, 2051-2056.
17. Kripke ML. (1974). J. Natl. Cancer Inst., 53, 1333-1336.
18. Kripke ML and Fisher MS. (1976). J. Natl. Cancer Inst., 57, 211-215.
19. Lu YP, Lou YR, Yen P, Mitchell D, Huang MT and Conney AH. (1999). Cancer Res, 59, 4591-4602.
20. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S and Papaioannou VE. (1992). Cell, 68, 869-877.
21. Moodycliffe AM, Nghiem D, Clydesdale G and Ullrich SE. (2000). Nat. Immunol, 1, 521-525.
22. Noonan FP and De Fabo EC. (1990). Photochem. Photobiol., 52, 801-810.
23. Oettinger MA, Schatz DG, Gorka C and Baltimore D. (1990). Science, 248, 1517-1523.
24. Ouhtit A, Muller HK, Davis DW, Ullrich SE, McConkey D and Ananthaswamy HN. (2000). Am. J. Pathol., 156, 201-207.
25. Rebel H, Mosnier LO, Berg RJW, Westeman-de Vires A, Steeg H, van Kranen HJ and de Gruijl F. (2001). Cancer Res., 61, 977-983.
26. Ren ZP, Hedrum A, Ponten F, Nister M, Ahmadian A, Lundeberg J, Uhlen M and Ponten J. (1996). Oncogene, 12, 765-773.
27. Schwarz A, Bhardwaj R, Aragane Y, Mahnke K, Riemann H, Metze D, Luger TA and Schwarz T. (1995). J. Invest. Dermatol., 104, 922-927.
28. Smyth MJ, Godfrey DI and Trapani JA. (2001). Nat. Immunol, 2, 293-299.
29. Strickland PT. (1986). Environ. Health Perspect., 68, 131-134.
30. Strickland PT and Swartz RP. (1987). Cancer Res., 47, 6294-6296.
31. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, Savill JS, Henson PM, Botto M and Walport MJ. (2000). J. Exp. Med., 192, 359-366.
32. Toda K, Miyachi Y, Kuribayashi K and Imamura S. (1986). J. Clin. Lab. Immunol., 20, 129-131.
33. Ullrich SE. (2000). Biochemical Modulation of Skin Reactions Kydonieus AF and Wille JJ (eds). CRC Press: Boca Raton, pp. 281-300.
34. Ullrich SE. (2002). Front Biosci, 7, d684-d703.
35. Zhang W, Remenyik E, Zelterman D, Brash DE and Wikonkal NM. (2001). Proc. Natl Acad. Sci. USA, 98, 13948-13953.
36. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. (1994). Nature, 372, 773-776.